Notably, the discrimination capacity in terms of detecting AD/MCI people is higher for BACE1 with respect to Aβ40/42 ratio, suggesting that BACE1 can intercept cognitive worsening at an earlier stage with respect to brain amyloidosis as revealed by Aβ40/42 ratio. The gene discussed is BACE1; the disease is Alzheimer disease.